High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: Correlation with dietary risk factors in India

Clinical Cancer Research

Volumn 3, Issue 11, 1997, Pages 2129-2136

  Gaur, Deepak ^a   Arora, Sonia ^a   Mathur, Meera ^a   Nath, Neera ^a   Chattopadhaya, Tushar Kant ^a   Ralhan, Ranju ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DIETARY INTAKE; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; DIET; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; EXONS; FEMALE; FOOD HABITS; GENES, P53; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INDIA; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030658758     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Montesano, R., Hollstein, M., and Hainaut, P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer, 69: 225-235, 1996.
2. Parkin, D. M., Pisanic P., and Fearlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54: 594-606, 1993.
3. Munoz, N., and Castellsague, X. Epidemiology of esophageal cancer. Eur. J. Gastroenterol. Hepatol., 6: 649-655, 1994.
4. Pottern, I. M., Morris, L. E., Blot, W. J., Regina, G. Z., and Joseph, F. F., Jr. Esophageal cancer among black men in Washington, D.C. I. Alcohol, tobacco and other risk factors. J. Natl. Cancer Inst. (Bethesda), 67: 777-783, 1981.
5. Yu, M. C., Garabrant, D. H., Peters, J. M., and Mack, T. M. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res., 48: 3843-3848, 1988.
6. LaVecchia, C., and Negri, E. The role of alcohol in esophageal cancer in non smokers and of tobacco in non drinkers. Int. J. Cancer, 43: 784-785, 1989.
7. Jayant, K., Balakrishnan, B., Sanghvi, L. D., and Jussawalla, D. J. Quantification of the role of smoking and chewing tobacco in oral pharangeal and oesophageal cancers. Br. J. Cancer, 35: 232-235, 1977.
8. Pintos, J., Franco, E. L., Oliveira, B. V., Kowalski, L. P., Curado, M. P., and Dewar, R. Mate coffee and tea and risk of cancers of the upper aerodigestive tract in Southern Brazil. Epidemiology, 5: 583-590, 1994.
9. Castelletto, R., Castellsague, X., Munoz, N., Iscovich, J., Chopita, N., and Jmelnitsky, A. Alcohol, tobacco, diet, mate drinking and esophageal cancer in Argentina. Cancer Epidemiol. Biomark. Prev., 3: 557-564, 1994.
10. Brown, L. M., Silverman, D. T., Pottern, L. M., Schoenberg, J. B., Greenberg, R. S., Swanson, G. M., Liff, J. M., Schwartz, A. G., Hayes, R. B., Blot, W. J., and Hoover, R. N. Adenocarcinoma of the esophagus and esophogastric junction in white men in the United States: alcohol tobacco and socio-economic factors. Cancer Causes Control, 5: 333-340, 1994.
11. Chow, W., Finkle, W. D., McLaughlin, J. K., Frankl, H., Ziel, H. K., and Fraumeni, J. F., Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinoma of the esophagus and gastric cardia. J. Am. Med. Assoc., 274: 474-477, 1995.
12. Craddock, V. M. In: M. M. Coombs, J. Ashby, and R. M. Hicks (eds.), Cancer of the Esophagus: Approaches to the Etiology, pp. 87-91. Cambridge, United Kingdom: Cambridge University Press, 1993.
13. Srivastava, M., Kapil, U., Chattopadhaya, T. K., Shukla, W. K., Gnanasekaran, N., Jain, G. L., Joshi, Y. K., and Nayar, D. Nutritional risk factors in carcinoma esophagus. Nutr. Res., 15: 177-185, 1995.
14. Wang, L. D., Zhou, Q., Hong, J. Y., Qiu, S. L., and Yang, C. S. p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China. Cancer, 77: 1244-1249, 1996.
15. Hollstein, M., Shormer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R., and Harris, C. C. Somatic point mutations in the p53 gene of human tumors and cell lines: update compilation. Nucleic Acid Res., 24: 141-146, 1996.
16. Hollstein, M. C., Metcalf, R. A., Welsh, J. A., Montesano, R., and Haris, C. C. Frequent mutations of the p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 87: 9958-9961, 1990.
17. Audrezet, M. P., Robaszkiewicz, M., Mercier, B., Nousbaum, J. B., Bail, J. P., Hardy, E., Volant, A., Lozach, P., Charles, J. F., Goueron, H., and Ferec, C. TP53 mutation profile in esophageal squamous cell carcinomas. Cancer Res. 53: 5745-5749, 1993.
18. Neshat, K., Sanchiez, C. A., Galipeau, P. C., Blount, P. L., Levine, D. S., Joslyn, G., and Reid, B. J. p53 mutations in Barrett's adenocarcinoma and high grade dysplasia. Gastroenterology, 106: 1589-1595, 1994.
19. Wagata, T., Shibagaki, I., Imamura, M., Shimada Y., Toguchida, J., Yaudell D. W., Ikenaga, M., Tobe, T., and Ischizaki K. Loss of 17p mutation of the p53 gene and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res., 53: 846-850, 1993.
20. Greenwald, B. D., Huang, Y., Baum, R., and Meltzen, S. J. Barrett's carcinoma in a 25-year-old man with point mutation of the p53 tumor suppressor gene. Int. J. Oncol., 1: 271-275, 1992.
21. Huang, Y., Meltzer, S. J., Tong Y., Chang, E. H., Srivastava, S., McDaniel T., Bynton, R. F., and Zou, Z. Q. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res., 53: 1889-1894, 1993.
22. Maesawa, C., Tamura, G., Suzuki, Y., Ishida, K., Saito, K., and Satodate, R. Sensitive detection of p53 gene mutations in esophageal endoscopic biopsy specimens by cell sorting combined with polymerase chain reaction single strand conformation polymorphism analysis. Jpn. J. Cancer, 83: 1253-1256, 1992.
23. Tamura, G., Maesawa, C., Suzuki, Y., Satodate, R., Ishida, K., and Satto, K. p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn. J. Cancer Res., 83: 559-562, 1992.
24. Bennett, W. P., Hollstein, M. C., He, A., Zhu, S. M., Resau, J. H., Trump, B. F., Metcalf, R. A., Welch, J. A., Midgley, C., Lane, D. P., and Harris, C. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene, 6: 1779-1784, 1991.
25. Chung, K. Y., Mukhopadhyay, T., Kim, J., Casson, A., Ro, J. Y., Goepfert, H., Hong, W. K., and Roth, J. A. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res., 53: 1676-1683, 1993.
26. Esteve, A., Lehman, T., Jiang, W., Weinstein, I. B., Harris, C. C., Ruyol, A., Reracchia, A., Montesano, R., and Hollstein, M. Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol. Carcinog., 8: 306-311, 1993.
27. Hollstein, M. C., Sidransky D., Vogelstein, B., and Harris C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
28. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981,
29. Maniatis, T., Fritsch, E. F., and Sambrook, J. (eds.). Molecular Cloning: A Laboratory Manual, pp. 9.14-9.23. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
30. Yap, E. P. H., and McGee, J. D. D. Non isotopic SSCP and competitive PCR for quantification of p53 in breast cancer cells. Nucleic Acid Res., 20: 145-152, 1992.
31. Siddiqi, M. A., Tricker, A. R., Fazili, Z., and Preussmann, R. In: I. K. O'Neill, J. Chen, and H. Bartsch (eds.). Dietary Sources of N-Nitrosamines in a High Risk Area for Oesophageal Cancer: Kashmir, India. Relevance to Human Cancer of N-Nitroso Compounds. Tobacco Smoke and Mycotoxins. Lyon, France: IARC, no. 105, 1991.
32. Siddiqi, M., Tricker, A. R., and Preussmann, R. The occurrence of preformed N-nitroso compounds in food samples from a risk area of esophageal cancer in Kashmir, India. Cancer Lett., 39: 37-43, 1988.
33. Agarwal, R. C., Hacker, E., Wiessler, M., and Bhide, S. U. Tumor promoting effect of chili extract in Balb/c mice. Int. J. Cancer, 38: 689-698, 1986.
34. Toth, B., Ragan, E., and Walker, B. Tumorigenicity and mutagenicity studies with capsaicin of hot peppers. Anticancer Res., 4: 117-120, 1984.
35. Nagbhushan, M., and Bhide, S. V. Mutagenicity of chili extract and capsaicin in short term tests. Exp. Mutag., 7: 881-886, 1985.
36. Monsereenusorn, Y., Kungsamutta, S., and Peezale, Y. Capsaicin: a literature survey. CRC Crit. Rev. Toxicol., 10: 336-339, 1982.
37. Nopanitya, W., and Nye, S. W. Duodenal mucosal response to the pungent principle of hot pepper (capsaicin) in the rat: light and electron microscope study. Toxicol. Appl. Pharmacol. 30: 149-161, 1974.
38. Scheider, M. A., DeLuca, V., and Gray, S. J. The effect of spice injection on stomach. Am. J. Gastroenterol., 26: 722-726, 1956.
39. Adamuya, I. K. The influence of red peppers (Capsicum annum) on the induction of liver tumors. Acad. Nank. Gruz. Soopchridge., 65: 237-239, 1971.
40. Lee, R., and Kurnar, S. In: M. J. Coon, R. W. Conney, R. W. Stabrook, H. V. Gelboin, J. R. Gillette, and P. J. O'Brien (eds.). Microsomes, Drugs, Oxidation and Chemical Carcinogenesis, Vol. 2, pp. 1009-1092. New York: Academic Press, 1980.
41. Miller, M. S., Brendal, K., Burks, T. F., and Sipes, J. G. Interaction of capsaicinoids with drug metabolizing systems. Relationship to toxicity. Biochem. Pharmacol., 32: 547-551, 1983.